Tag: biosimilar
-
Trump Administration Releases Drug Pricing Blueprint
On May 11, The Trump Administration released “American Patients First,” the President’s blueprint to lower drug prices and reduce out-of-pocket costs, along with a request for information. The Blueprint was framed as advancing four specific goals: Reducing list prices; Improving government’s ability to negotiate better prices; Encouraging competition through rapid entry to market of generics and…